Clinical Trial

Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-12.
Status change: Not Yet Recruiting → Recruiting 2025-02-13
Trial Details
NCT Number NCT06778954
Lead Sponsor Gangnam Severance Hospital
Conditions Gastric Cancer
Enrollment 48 participants
Start Date 2025-01-30
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-14